Intravascular Ultrasound [IVUS] Devices Market Forecasts to 2028 – Global Analysis By Product (Accessories, Consoles), Application (Coronary Diagnosis, Coronary Research), End User (Hospitals, Specialty Clinics) and By Geography
According to Stratistics MRC, the Global Intravascular Ultrasound [IVUS] Devices Market is accounted for $360.32 million in 2020 and is expected to reach $676.87 million by 2028 growing at a CAGR of 8.2% during the forecast period. The technological advancements, inclination towards less invasive procedures, increase in the image output quality and developments in the image-guided therapeutic treatment are driving the market growth. However, high costs and lack of uniform reimbursement are hampering the growth of the market.
Intravascular ultrasound (IVUS) is a medical imaging methodology using a specially designed catheter with a miniaturized ultrasound probe attached to the distal end. The proximal end of the catheter is attached to computerized ultrasound equipment. It allows the application of ultrasonic technology to visualize the blood vessels internally through the surrounding blood column.
Based on the modality, the IMap IVUS segment is going to have lucrative growth during the forecast period owing to its applications such as tissue characterization by using histology derived database and frequency spectrum and provides a better classification of plaque by involving more calculations than virtual histology.
By geography, North America is going to have high growth during the forecast period. The growth in this segment is owing to the factors such as advancements in technology, the growing prevalence of coronary artery diseases, and rapid growth in the healthcare infrastructure, and an increase in the number of diseases.
Some of the key players profiled in the Intravascular Ultrasound [IVUS] Devices Market include Allergan plc, AstraZeneca, Bayer HealthCare Pharmaceuticals, Biogen, Inc., GlaxoSmithKline Plc, H. Lundbeck A/S, Johnson & Johnson, Novartis AG, Parion Sciences, Inc., Pfizer Inc and Sanofi S.A.
Estimated Market Size in 2020:
USD 360.32 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 676.87 million
Tables, Graphs& Figures
Product, Modality, Application, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• IMap IVUS
• Integrated Backscatter IVUS
• Virtual Histology IVUS
• Coronary Diagnosis
• Coronary Intervention
• Coronary Research
• Non-coronary /Peripheral Applications
End Users Covered:
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Mobile Imaging Centers
• Research and Academic Institutions
• Specialty Clinics
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Intravascular Ultrasound [IVUS] Devices Market is majorly driven by the technological advancements, inclination towards less invasive procedures and increase in the image output quality.
The IMap IVUS segment is growing at a highest CAGR owing its applications such as tissue characterization by using histology derived database and provides a better classification of plaque.
Asia Pacific dominated with a significant market share due to rise in patient pool, increasing disposable income of the population & pharmaceutical industries, and rising frequencies of cardiovascular disorders in the region.
North America market is growing at a highest CAGR owing to the factors such as advancements in technology, rapid growth in the healthcare infrastructure, and an increase in the number of diseases.
Key players in Intravascular Ultrasound [IVUS] Devices Market include Allergan plc, AstraZeneca, Bayer HealthCare Pharmaceuticals, Biogen, Inc., GlaxoSmithKline Plc, H. Lundbeck A/S, Johnson & Johnson, Novartis AG, Parion Sciences, Inc., Pfizer Inc and Sanofi S.A.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.